2-(4-Ethoxyphenoxy)-5-(morpholine-4-sulfonyl)aniline, 97%, 250mg

N-Benzyl-4-bromo-5-fluoro-2-nitroaniline, 95.0%, 5g

4-Chloro-3-methyl-6-nitrophenol, 95.0%, 10g

3-HYDROXY-ISONICOTINAMIDE, 97.0%, 250mg

4-(4-Chloro-6-methoxy-9h-pyrimido[4,5-b]indol-7-yl)-3,5-dimethyl-isoxazole, 98%, 500mg

6-Methyl-4-pyrimidinamine, 95.0%, 250mg

ETHYL 5-CHLOROPYRIMIDINE-2-CARBOXYLATE, 95.0%, 100mg

1-Ethyl-2-iodo-3-methylbenzene, 98%, 10g

Obiettivo piano PLPHi 10x/0,25 contrasto di fase IOS corretto all'infinito

6-Chloro-2,4-dimethylpyridin-3-amine, 95%, 250mg

2-Methoxy-6-(piperidin-3-yloxy)pyridine hydrochloride, 100mg

3,6-Di-tert-butylacridin-9(10H)-one, 98%, 250mg

6-Chloro-2,3-difluoroaniline, 250mg